glp-1 news today pharma today A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for Lilly is now pharma's top

Unlike prescription medications, food supplements are not subject to the same stringent manufacturing and quality controls

GLP-1 drug users by working status According to the data, users generally fall into higher income brackets, with most GLP-1 users falling into the higher and intermediate management roles

intra-articular injection directly into the joint (physician-administered, for knee, shoulder, wrist, and hip conditions)

A separate 2026 systematic review in the medical journal, The BMJ, found that weight returned at an average rate of about 0.4 kilograms roughly one pound per month after stopping weight-management medication, putting many patients on track to return to their starting weight within about 1.5 to 2 years without ongoing treatment